| Derivatives and Hedging Instruments The Company may periodically enter into derivative financial instruments to manage risks related to interest rates and foreign currency. Certain of the Company’s derivative financial instruments qualify for hedge accounting treatment. The following table summarizes the fair value of derivative instruments as recorded in the Company’s condensed consolidated statements of financial condition (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | September 30, 2026 | | December 31, 2025 | | Balance Sheet Location | | Fair Value | | Balance Sheet Location | | Fair Value | | | | | | | | | | Interest rate cap contracts | Other assets | | $ | 3,435 | | | Other assets | | $ | 286 | | | Interest rate swap agreements | Other assets | | 1,230 | | | — | | | — | | | Interest rate swap agreements | Other liabilities | | (279) | | | Other liabilities | | (16,338) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivatives Designated as Hedging Instruments The Company may periodically enter into interest rate swap agreements and interest rate cap contracts to reduce its exposure to fluctuations in interest rates on variable interest rate debt and their impact on earnings and cash flows. Under the interest rate swap agreements, the Company receives floating interest rate payments and makes interest payments based on fixed interest rates. Under the interest rate cap contracts, the Company pays an upfront premium in exchange for receiving payments when the reference floating interest rate exceeds the contractual cap rate. The Company designates its interest rate swap and interest rate cap instruments as cash flow hedges at inception. The following tables summarize the terms of the derivative instruments designated as hedging instruments as recorded in the Company’s condensed consolidated statements of financial condition:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | September 30, 2026 | | Effective date | | Maturity Date | | Hedge Designation | | Notional Amount | | Receive Floating Rate Index | | | | | | | | | | | | Interest rate cap contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2025 Cap | September 2026 | | January 2028 | | Cash flow hedge | | $338.2 million | | SONIA | 2025 Cap - U.S. Facility | December 2025 | | October 2028 | | Cash flow hedge | | $130.0 million | | 1-month SOFR CME Term | | 2026 Cap | January 2028 | | January 2029 | | Cash flow hedge | | $338.2 million | | SONIA | | Interest rate swap agreements | | | | | | | | | | 2023 Euro IR Swap | October 2023 | | January 2028 | | Cash flow hedge | | $113.3 million | | 3-month EURIBOR | | 2024 Euro IR Swaps | June 2024 | | January 2028 | | Cash flow hedge | | $470.2 million | | 3-month EURIBOR | 2023 SOFR IR Swaps - U.S. Facility | November 2023 | | October 2026 | | Cash flow hedge | | $150.0 million | | 1-month SOFR CME Term | 2025 SOFR IR Swaps - U.S. Facility | January 2025 | | October 2027 | | Cash flow hedge | | $125.0 million | | 1-month SOFR CME Term | 2025 SOFR IR Swaps - Global Senior Facility | April 2025 | | April 2027 | | Cash flow hedge | | $150.0 million | | 1-month SOFR CME Term | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
In October 2026, the Company entered into new interest rate swap contracts (the “2026 Swaps”) with an aggregate notional amount of $150.0 million to replace the 2023 SOFR IR Swaps - U.S. Facility, that matured on October 27, 2026. The 2026 Swaps are intended to hedge the Company’s exposure to fluctuations in interest payments on debt bearing variable interest based on one-month CME Term SOFR. The 2026 Swaps became effective in October 2026 and will mature in October 2029. The 2026 Swaps are designated as a cash flow hedge. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2025 | | Effective date | | Maturity Date | | Hedge Designation | | Notional Amount | | Receive Floating Rate Index | | | | | | | | | | | | Interest rate cap contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2024 Cap | September 2024 | | September 2026 | | Cash flow hedge | | $343.5 million | | SONIA | | 2025 Cap | September 2026 | | January 2028 | | Cash flow hedge | | $343.5 million | | SONIA | 2025 Cap - U.S. Facility | December 2025 | | October 2028 | | Cash flow hedge | | $130.0 million | | 1-month SOFR CME Term | | | | | | | | | | | | Interest rate swap agreements | | | | | | | | | | 2023 Euro IR Swap | October 2023 | | January 2028 | | Cash flow hedge | | $117.5 million | | 3-month EURIBOR | 2024 Euro IR Swaps | June 2024 | | January 2028 | | Cash flow hedge | | $487.5 million | | 3-month EURIBOR | 2023 SOFR IR Swaps - U.S. Facility | November 2023 | | October 2026 | | Cash flow hedge | | $150.0 million | | 1-month SOFR CME Term | | 2025 SOFR IR Swaps - U.S. Facility | January 2025 | | October 2027 | | Cash flow hedge | | $125.0 million | | 1-month SOFR CME Term | | 2025 SOFR IR Swaps - Global Senior Facility | April 2025 | | April 2027 | | Cash flow hedge | | $150.0 million | | 1-month SOFR CME Term | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The Company expects to reclassify approximately $0.8 million of net derivative loss from OCI into earnings relating to its derivatives designated as cash flow hedges within the next 12 months. This amount will vary due to fluctuations in benchmark interest rates. The following table summarizes the effects of derivatives designated as hedging instruments in the Company’s condensed consolidated financial statements (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Derivatives Designated as Hedging Instruments | | Gain (Loss) Recognized in OCI | | Location of Loss Reclassified from OCI into Income | | Loss Reclassified from OCI | | Three Months Ended September 30, | | | Three Months Ended September 30, | | 2026 | | 2025 | | | 2026 | | 2025 | | | | | | | | | | | | | | | | | | | | | | | | Interest rate swap agreements | | $ | 5,400 | | | $ | 2,251 | | | Interest expense | | $ | (1,525) | | | $ | (1,368) | | | Interest rate cap contracts | | 2,064 | | | (302) | | | Interest expense | | (542) | | | (416) | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Derivatives Designated as Hedging Instruments | | Gain (Loss) Recognized in OCI | | Location of Loss Reclassified from OCI into Income | | Loss Reclassified from OCI | | Nine Months Ended September 30, | | | Nine Months Ended September 30, | | 2026 | | 2025 | | | 2026 | | 2025 | | | | | | | | | | | | | | | | | | | | | | | | Interest rate swap agreements | | $ | 11,800 | | | $ | (3,558) | | | Interest expense | | $ | (5,489) | | | $ | (2,878) | | | Interest rate cap contracts | | 1,711 | | | (1,621) | | | Interest expense | | (1,550) | | | (1,194) | | | | | | | | | | | | | | | | | | | | | | | |
|